Bergen Brunswig Corp.: The Orange company, the...

Bergen Brunswig Corp.: The Orange company, the nation’s largest supplier of pharmaceuticals to the managed-care market and the second largest wholesaler to the retail pharmacy market, reported that net earnings in the fiscal year ended Sept. 30 rose 14% to $63.9 million, or $1.61 a share, from $56.1 million, or $1.45 a share, for the prior year. Revenue increased 12% to $8.4 billion from $7.5 billion. Fourth-quarter profit was down 3% to $15.7 million, or 39 cents a share, from $16.2 million, or 41 cents a share, a year earlier. Included in last year’s fourth quarter was an unusual gain from the sale of investment securities, the company said. Revenue was up 16% to $2.2 billion, up from $1.9 billion.